Table 1 Univariate analysis of the associations between prognostic variables and overall survival or disease-free survival in 136 cases of stage I non-small-cell lung cancer
From: Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancer
Patient and tumour characteristics | Number of cases | P -value overall survival | P -value disease-free survival |
|---|---|---|---|
Sex | |||
Male | 126 | ||
Female | 10 | 0.37 | 0.56 |
Age (years) | |||
⩽66 | 64 | ||
>66 | 72 | 0.48 | 0.47 |
Tumour grade (G) | |||
G1 | 39 | ||
G2 | 57 | ||
G3 | 40 | 0.070 | 0.0059 |
Histology | |||
Squamous | 84 | ||
Nonsquamous | 52 | 0.79 | 0.88 |
Tumour size (T) | |||
T1 | 54 | ||
T2 | 82 | 0.39 | 0.37 |
Osteopontin expression (OPN %) | |||
Low (<20) | 65 | ||
High (⩾20) | 71 | 0.034 | 0.011 |
Osteopontin (OPN+) | |||
0 | 38 | ||
+ | 40 | ||
++ | 36 | ||
+++ | 22 | 0.11 | 0.090 |
